Retrograde Ejaculation

Retrograde ejaculation is a reproductive disorder characterized by the propulsion of semen into the urinary bladder instead of through the urethra to the exterior during ejaculation. This occurs due to failure of the internal urethral sphincter (bladder neck) to close during the ejaculatory reflex, allowing semen to flow backward. In veterinary medicine, this condition is primarily recognized in dogs, though it can occur in other species. It is a cause of male infertility, as the ejaculate is either absent (aspermia) or markedly reduced in volume, with spermatozoa found in post-ejaculatory urine. The condition may be congenital or acquired, and it is often associated with neurological deficits, iatrogenic causes (e.g., alpha-adrenergic antagonist administration), or prostatic disease. Diagnosis is confirmed by the presence of spermatozoa in urine collected immediately after ejaculation. Treatment aims to enhance sympathetic tone to the internal urethral sphincter or to manage the underlying cause.

The etiology of retrograde ejaculation in male animals can be classified into neurogenic, myogenic, iatrogenic, and obstructive causes. Neurogenic causes include spinal cord lesions, autonomic neuropathy (e.g., dysautonomia), or damage to the hypogastric nerve, which provides sympathetic innervation to the internal urethral sphincter. Myogenic causes involve incompetence of the internal urethral sphincter due to congenital weakness or acquired damage from trauma, surgery (e.g., prostatectomy), or chronic urethritis. Iatrogenic causes are significant in veterinary practice: administration of alpha-adrenergic antagonists (e.g., phenoxybenzamine, prazosin) used to manage urethral obstruction or hypertension can relax the internal sphincter, leading to retrograde flow. Similarly, drugs that reduce sympathetic tone, such as some tranquilizers (e.g., acepromazine), may predispose. Prostatic disease, including prostatitis, prostatic cysts, or neoplasia, can disrupt the normal anatomical and neural integrity of the bladder neck. Endocrine imbalances, such as hypothyroidism or hypoadrenocorticism, may alter autonomic function. In some cases, the cause is idiopathic. In breeding dogs, retrograde ejaculation may be suspected when a dog mounts and thrusts but produces no semen, yet urine collected post-mating contains spermatozoa.

Retrograde ejaculation is an uncommon cause of male infertility in domestic animals, with limited epidemiological data. It is most frequently reported in dogs, particularly in breeds with a high incidence of prostatic disease, such as the Doberman Pinscher, German Shepherd, and Boxer, though no strong breed predisposition is established. The condition can occur at any age but is more common in middle-aged to older dogs, correlating with the onset of prostatic hyperplasia or neoplasia. In cats, retrograde ejaculation is rarely diagnosed, possibly due to the difficulty in semen collection and the species' unique reproductive physiology. There is no known sex predilection (as it is a male-only condition). The incidence is likely underreported because many cases are misdiagnosed as aspermia or ejaculatory failure. In breeding programs, the condition can have significant economic impact, as affected males may be deemed infertile. Iatrogenic cases may be more frequent in clinical settings where alpha-blockers are prescribed for urethral obstruction, but the exact incidence is unknown.

The pathophysiology of retrograde ejaculation involves a failure of the internal urethral sphincter (bladder neck) to contract during ejaculation. Normal ejaculation is a complex reflex coordinated by the sympathetic nervous system (hypogastric nerve) and somatic nerves (pudendal nerve). During the emission phase, sympathetic stimulation causes contraction of the smooth muscle of the epididymis, vas deferens, and prostate, propelling semen into the prostatic urethra. Simultaneously, the internal urethral sphincter contracts to prevent retrograde flow into the bladder, while the external urethral sphincter relaxes to allow antegrade expulsion. If the internal sphincter fails to contract, the increased pressure in the prostatic urethra forces semen into the bladder. This can result from damage to the sympathetic innervation (e.g., spinal cord injury, surgical trauma), incompetence of the sphincter muscle itself, or pharmacological relaxation. In cases of prostatic disease, inflammation or neoplasia may disrupt the neural pathways or mechanically impair sphincter function. The consequence is that the ejaculate is either absent or markedly reduced, with spermatozoa present in the urine. The spermatozoa in the bladder are exposed to urine, which is hyperosmolar and acidic, leading to rapid loss of motility and viability, further contributing to infertility.

Predisposing factors for retrograde ejaculation include: (1) Neurological disorders: intervertebral disc disease, spinal cord trauma, degenerative myelopathy, or autonomic neuropathy can impair sympathetic innervation. (2) Prostatic disease: benign prostatic hyperplasia, prostatitis, prostatic abscess, or neoplasia can disrupt the anatomy and neural function of the bladder neck. (3) Iatrogenic: surgical procedures such as prostatectomy, cystotomy, or perineal hernia repair may damage the hypogastric nerve or internal sphincter. (4) Pharmacological: administration of alpha-adrenergic antagonists (e.g., phenoxybenzamine, prazosin) for urethral obstruction or hypertension, or drugs with anticholinergic effects, can cause sphincter relaxation. (5) Congenital anomalies: rare congenital weakness of the internal sphincter. (6) Endocrine disorders: hypothyroidism or hypoadrenocorticism may alter autonomic tone. (7) Trauma: pelvic fractures or blunt trauma to the pelvic region can damage the nerves or sphincter. (8) Age: older animals are more prone to prostatic disease and neurological degeneration. (9) Breed: certain breeds may have a higher incidence of prostatic disease, indirectly increasing risk. (10) Stress or behavioral factors: anxiety during collection may interfere with the ejaculatory reflex, though this is less well-defined.

The primary clinical sign of retrograde ejaculation is the absence or marked reduction of ejaculate volume during semen collection, despite normal mounting, thrusting, and penile erection. The dog may show signs of ejaculation (pelvic thrusting, penile tumescence) but no seminal fluid is emitted. In some cases, a small amount of clear fluid may be present, representing urethral gland secretions. The animal may also have a history of infertility when used for breeding. Other signs may be related to the underlying cause, such as signs of prostatic disease (hematuria, dysuria, tenesmus, purulent urethral discharge), neurological deficits (hindlimb weakness, ataxia, urinary incontinence), or systemic signs if infection is present (fever, lethargy). On physical examination, the prostate may be enlarged or painful on rectal palpation. Neurological examination may reveal deficits consistent with spinal cord lesions. If the condition is iatrogenic, the history will include recent drug administration or surgery. In some cases, the only abnormality is the absence of sperm in the ejaculate, with spermatozoa found in urine collected immediately after ejaculation.

Differential diagnoses for retrograde ejaculation include: (1) Aspermia due to ejaculatory failure: the dog may not ejaculate due to psychological inhibition, pain, or lack of libido; urine will not contain sperm. (2) Partial ejaculatory obstruction: urethral stricture, calculi, or neoplasia may impede semen flow; urine may contain sperm if retrograde occurs, but other signs like dysuria may be present. (3) Prostatic disease: prostatitis, prostatic cysts, or neoplasia can cause hematospermia or pyospermia, but ejaculate volume is usually normal. (4) Testicular failure: azoospermia due to testicular degeneration or hypoplasia; ejaculate volume may be normal but sperm count is zero, and urine will not contain sperm. (5) Epididymal obstruction: sperm are present in the ejaculate but in low numbers; urine will not contain sperm. (6) Urethritis: inflammation may cause discharge, but ejaculate volume is normal. (7) Neurological disorders: spinal cord lesions may cause ejaculatory dysfunction, but retrograde flow is not always present. (8) Pharmacological effects: alpha-blockers may cause retrograde ejaculation, but other causes must be ruled out. (9) Congenital abnormalities: such as urethral ectopia or persistent urachus, which may cause urine to mix with semen. (10) Psychogenic infertility: behavioral issues may prevent ejaculation, but urine will not contain sperm.

The diagnostic algorithm for retrograde ejaculation begins with a thorough history and physical examination, including neurological and rectal examination. The next step is semen collection: if the dog fails to produce an ejaculate or produces a low-volume ejaculate, a urine sample should be collected immediately after the attempted collection (within 5-10 minutes). The urine is centrifuged and the sediment examined for spermatozoa. If sperm are present, retrograde ejaculation is confirmed. To differentiate from ejaculatory failure, the urine should be collected after a successful erection and thrusting. If the dog does not ejaculate at all, the urine may not contain sperm. Further diagnostic tests include: (1) Urinalysis to assess urine pH and osmolality, which may affect sperm viability. (2) Serum hormone assays (testosterone, LH, FSH) to rule out testicular dysfunction. (3) Ultrasonography of the prostate and bladder to evaluate for prostatic disease or bladder neck abnormalities. (4) Urethrocystoscopy to visualize the internal urethral sphincter and rule out anatomical lesions. (5) Neurological evaluation, including spinal radiographs or MRI if a spinal lesion is suspected. (6) If iatrogenic, review of medications. (7) In breeding animals, a breeding soundness examination should be performed, including testicular palpation and semen evaluation. The diagnostic algorithm should be systematic to rule out other causes of aspermia or azoospermia.

Laboratory findings in retrograde ejaculation are primarily based on urinalysis and semen evaluation. Urine collected immediately after ejaculation will contain spermatozoa, which can be visualized on microscopic examination of the urine sediment. The urine may have a low pH (acidic) and high osmolality, which can impair sperm motility. Hematology and serum biochemistry are usually unremarkable unless there is an underlying systemic disease (e.g., prostatitis may cause leukocytosis). Serum testosterone levels may be normal, as testicular function is typically unaffected. If prostatic disease is present, prostatic fluid may show inflammatory cells (neutrophils) and bacteria on culture. Vaginal cytology is not applicable in males. In cases of iatrogenic retrograde ejaculation, no specific laboratory abnormalities are expected. If neurological disease is suspected, cerebrospinal fluid analysis may be indicated. Hormonal assays (LH, FSH) may be useful to differentiate testicular failure, but in retrograde ejaculation, these are usually normal. Semen analysis, if an ejaculate is obtained, may show a low volume with normal sperm concentration, but often the ejaculate is absent.

Imaging modalities are useful to identify underlying causes of retrograde ejaculation. Abdominal ultrasonography is the primary imaging tool: it can assess the prostate for size, echotexture, cysts, abscesses, or neoplasia. The bladder should be evaluated for the presence of urine and any abnormalities of the bladder neck. Ultrasonography can also visualize the urethra, though it is not as detailed as contrast studies. Radiography of the pelvis may reveal fractures or foreign bodies, but it is less sensitive for soft tissue lesions. Contrast urethrocystography (retrograde urethrogram) can outline the urethra and bladder neck, potentially showing reflux of contrast into the bladder during ejaculation, but this is rarely performed. Urethrocystoscopy is the most definitive imaging technique: it allows direct visualization of the internal urethral sphincter and can detect anatomical abnormalities, inflammation, or masses. In cases of suspected neurological disease, MRI of the spine may be indicated to identify spinal cord compression or lesions. In breeding animals, ultrasonography of the testes and epididymides may be performed to rule out testicular pathology. Overall, imaging is essential to identify treatable causes such as prostatic disease or urethral obstruction.

Cytology and histopathology are not typically required for the diagnosis of retrograde ejaculation, but they are useful when an underlying cause is suspected. If prostatic disease is present, fine-needle aspiration of the prostate can be performed for cytology: findings may include neutrophils, macrophages, bacteria, or neoplastic cells. Histopathology of prostatic biopsies can confirm prostatitis, benign prostatic hyperplasia, or prostatic adenocarcinoma. In cases of urethral masses, biopsy via urethrocystoscopy can provide a definitive diagnosis. Testicular biopsy is rarely indicated unless testicular failure is suspected; histopathology may show degeneration, atrophy, or neoplasia. In retrograde ejaculation, the testes are usually normal, so biopsy is not recommended. If a neurological cause is suspected, histopathology of nerve tissue is not feasible in live animals. Overall, cytology and histopathology are ancillary tests to identify the underlying etiology, not to confirm retrograde ejaculation itself.

Treatment of retrograde ejaculation depends on the underlying cause. If iatrogenic, discontinuation of the offending drug (e.g., alpha-blockers) may resolve the condition. For neurogenic causes, management of the underlying neurological disease is essential, but specific therapy for retrograde ejaculation may be attempted. Pharmacological therapy aims to increase sympathetic tone to the internal urethral sphincter. Alpha-adrenergic agonists such as phenylpropanolamine (1.5-2 mg/kg PO q8h in dogs) or pseudoephedrine (1-2 mg/kg PO q8h) may be used to stimulate contraction of the bladder neck. Imipramine, a tricyclic antidepressant with anticholinergic and alpha-adrenergic effects, has been used at 2-4 mg/kg PO q12h in dogs. These drugs may be given 1-2 hours before semen collection to facilitate antegrade ejaculation. In cases of prostatic disease, treatment of the underlying condition (e.g., antibiotics for prostatitis, castration for benign prostatic hyperplasia) may resolve the retrograde ejaculation. If medical therapy fails, surgical options are limited; in severe cases, urethral sphincter reconstruction may be attempted but is rarely performed in veterinary medicine. For breeding purposes, artificial insemination with sperm collected from the bladder is possible: urine is collected immediately after ejaculation, centrifuged, and the sperm pellet is resuspended in a suitable extender for insemination. This technique can preserve fertility. Supportive care includes managing any urinary tract infections that may result from sperm in the bladder.

The prognosis for retrograde ejaculation depends on the underlying cause and response to treatment. If the condition is iatrogenic and the offending drug is discontinued, the prognosis is excellent, with normal ejaculation typically returning within days. If the cause is prostatic disease, successful treatment of the prostatic condition (e.g., castration for BPH, antibiotics for prostatitis) may restore normal ejaculation, and the prognosis is good. If the cause is neurological, the prognosis is guarded, as nerve damage may be irreversible. In cases where medical therapy with alpha-adrenergic agonists is effective, the prognosis for ejaculation is good, but long-term medication may be required. For breeding purposes, even if antegrade ejaculation cannot be restored, the dog may still be used for artificial insemination with sperm harvested from the bladder, allowing for genetic propagation. The overall fertility prognosis is therefore fair to good if the underlying cause is manageable. However, if the condition is due to severe neurological damage or neoplasia, the prognosis is poor. Recurrence is possible if the underlying cause persists.

Follow-up for retrograde ejaculation involves monitoring the response to treatment and assessing ejaculatory function. If pharmacological therapy is initiated, the dog should be re-evaluated within 1-2 weeks to assess whether ejaculation has improved. Semen collection should be attempted, and if successful, the ejaculate should be evaluated for volume, sperm count, and motility. If the dog is being used for breeding, a breeding soundness examination should be repeated after treatment. For dogs with prostatic disease, follow-up ultrasonography may be recommended to monitor resolution of prostatic changes. If the dog is on long-term medication, periodic blood pressure monitoring may be indicated, as alpha-adrenergic agonists can cause hypertension. If the dog is being used for artificial insemination with bladder-harvested sperm, the collection and processing protocol should be optimized, and the bitch's pregnancy rate should be monitored. In cases of neurological disease, follow-up neurological examinations are necessary. The frequency of follow-up depends on the underlying cause and response to therapy, but generally, re-evaluation at 2-4 week intervals is reasonable until the condition is stable.

Clinical pearls: (1) Always collect a urine sample immediately after an unsuccessful semen collection to rule out retrograde ejaculation. (2) Phenylpropanolamine or imipramine can be used to enhance bladder neck closure; administer 1-2 hours before collection. (3) Sperm harvested from the bladder can be used for artificial insemination; process the urine immediately to minimize sperm damage. (4) In dogs with prostatic disease, treating the prostate may resolve retrograde ejaculation. (5) Iatrogenic cases are common; review the drug history for alpha-blockers. Pitfalls: (1) Mistaking retrograde ejaculation for ejaculatory failure or aspermia; urine analysis is essential. (2) Failing to consider underlying neurological or prostatic disease. (3) Using drugs that may exacerbate the condition, such as alpha-blockers. (4) Not adjusting urine pH or osmolality when harvesting sperm from the bladder; sperm viability is poor in acidic urine. (5) Assuming the condition is permanent; many cases are treatable. (6) Overlooking the possibility of concurrent urinary tract infection due to sperm in the bladder.

Current drug protocols for retrograde ejaculation focus on enhancing sympathetic tone to the internal urethral sphincter. Phenylpropanolamine (PPA) is a sympathomimetic amine with alpha-adrenergic activity; the canine dosage is 1.5-2 mg/kg orally every 8 hours. It is available as a 50 mg tablet or as a compounded formulation. Pseudoephedrine, another alpha-agonist, can be used at 1-2 mg/kg orally every 8 hours, but it is less commonly used due to its stimulant effects. Imipramine, a tricyclic antidepressant, has both anticholinergic and alpha-adrenergic effects; the canine dosage is 2-4 mg/kg orally every 12 hours. It may be more effective in some cases. These medications should be given 1-2 hours before anticipated ejaculation to maximize their effect. In cases of prostatic disease, appropriate antibiotics (e.g., enrofloxacin 5-10 mg/kg PO q12h, or clindamycin 5-10 mg/kg PO q12h) should be administered for 4-6 weeks. For benign prostatic hyperplasia, castration is the treatment of choice; medical alternatives include finasteride (0.1-0.5 mg/kg PO q24h) or osaterone acetate (0.25-0.5 mg/kg PO q24h for 7 days). If neurological disease is present, treatment is directed at the underlying cause; corticosteroids (e.g., prednisone 0.5-1 mg/kg PO q24h) may be used for spinal cord inflammation. All drug protocols should be based on Plumb's Veterinary Drug Handbook and adjusted for individual patient needs.

Evidence-based literature on retrograde ejaculation in veterinary medicine is limited, with most information extrapolated from human medicine. In dogs, case reports and small case series have described the use of alpha-adrenergic agonists to manage the condition. A study by Johnston et al. (2001) in Canine and Feline Theriogenology noted that retrograde ejaculation is an uncommon cause of infertility and recommended urine examination after ejaculation for diagnosis. Noakes et al. (2019) in Veterinary Reproduction and Obstetrics discussed the pathophysiology and treatment options, emphasizing the role of sympathetic innervation. England and von Heimendahl (2010) in the BSAVA Manual of Small Animal Reproduction provided practical guidelines for semen collection and diagnosis. A case report by Kutzler (2005) described successful use of imipramine in a dog with retrograde ejaculation. Another study by Pena et al. (2003) evaluated the use of phenylpropanolamine in dogs with urethral sphincter incompetence, which may have implications for retrograde ejaculation. The consensus among experts is that retrograde ejaculation is a treatable condition, and early diagnosis is key. There are no large-scale clinical trials, but the available evidence supports the use of alpha-adrenergic agonists and the feasibility of artificial insemination with bladder-harvested sperm. Further research is needed to establish optimal treatment protocols.